SpringWorks Therapeutics Inc Ordinary Shares SWTX
News
SpringWorks Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors
SpringWorks Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm
SpringWorks stock on track for record gain after FDA approves first treatment for rare type of aggressive tumors
SpringWorks Shares Rise on FDA Approval for Tumor Treatment
SpringWorks Gets FDA Approval for Desmoid Tumor Treatment